Pharmacokinetics and Pharmacodynamics Practice Questions

Q: The study dealing with the effect of drugs on the body is known as:

Pharmacodynamics.. ### Explanation **Pharmacodynamics** is the correct answer because it describes **"what the drug does to the body."** It focuses on the biochemical and physiological effects of drugs and their mechanisms of action. This includes drug-receptor interactions, dose-response relationships, and the resulting therapeutic or toxic effects. The term is derived from the Greek words *pharmakon* (drug) and *dynamis* (power). **Analysis of Incorrect Options:** * **Pharmacokinetics:** This refers to **"what the body does to the drug."** It involves the quantitative study of drug movement through the body, specifically the processes of **ADME**: Absorption, Distribution, Metabolism, and Excretion. * **Drug kinetics:** This is a general term often used interchangeably with pharmacokinetics, specifically focusing on the rates of drug movement and elimination (e.g., zero-order or first-order kinetics). It does not describe the drug's effect on the body. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Remember **D** for **D**ynamics = **D**rug’s action; **K** for **K**inetics = Movement (**K**inetic energy). * **Key Parameters:** Pharmacodynamics deals with **Efficacy** (Emax) and **Potency** (EC50), whereas Pharmacokinetics deals with **Bioavailability, Volume of Distribution (Vd), and Half-life (t½).** * **Receptor Regulation:** A crucial part of pharmacodynamics is understanding **Down-regulation** (seen in chronic agonist use, e.g., Salbutamol in asthma) and **Up-regulation** (seen in chronic antagonist use, e.g., Propranolol).

Q: Which of the following is a Cytochrome P450 inhibitor?

Ketoconazole. **Explanation:** The correct answer is **Ketoconazole**. This question tests the fundamental pharmacological concept of drug-metabolizing enzyme modulation, specifically the Cytochrome P450 (CYP450) system. **1. Why Ketoconazole is correct:** Ketoconazole is a potent **enzyme inhibitor** [1], [2], [3]. It binds to the iron atom of the heme group in CYP450 enzymes (specifically CYP3A4), preventing the oxidation of other drugs [1]. This leads to decreased metabolism and increased plasma concentrations of co-administered drugs (e.g., Warfarin, Statins), potentially leading to toxicity [2]. **2. Why the other options are incorrect:** * **Rifampicin:** This is a classic, potent **enzyme inducer** [2]. It increases the synthesis of CYP450 enzymes, leading to faster metabolism and reduced efficacy of co-administered drugs (e.g., Oral Contraceptive Pills, leading to contraceptive failure). * **Phenytoin:** This is also a well-known **enzyme inducer**. Like Rifampicin, it accelerates the clearance of other drugs metabolized by the liver. **3. High-Yield Clinical Pearls for NEET-PG:** To remember these for the exam, use these popular mnemonics: * **Enzyme Inhibitors (VITAMINS K):** **V**alproate, **I**soniazid, **T**rimethoprim, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**etilmicin (and other Azoles like **Ketoconazole**), **S**ulfonamides, **C**imetidine, **G**rapefruit juice. * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. **Key Fact:** Ketoconazole is also known to inhibit steroid synthesis (adrenal and gonadal) [1], [3], which is why it can cause side effects like gynecomastia in males.

Q: Which drug is not acetylated?

Metoclopramide. **Explanation:** The question tests your knowledge of **Phase II metabolic reactions**, specifically **Acetylation**. This process is mediated by the enzyme **N-acetyltransferase (NAT)** in the liver. **Why Metoclopramide is the correct answer:** Metoclopramide is a prokinetic and antiemetic drug that primarily undergoes **Glucuronidation** and **Sulfate conjugation** (Phase II) and some oxidation (Phase I). It is not metabolized via the acetylation pathway. **Why the other options are incorrect:** Options A, B, and C are classic examples of drugs that undergo acetylation. A high-yield mnemonic to remember these is **"SHIP"**: * **S – Sulfonamides** (and **Dapsone**, which is a related sulfone) * **H – Hydralazine** * **I – Isoniazid (INH)** * **P – Procainamide** **Clinical Pearls for NEET-PG:** 1. **Genetic Polymorphism:** Acetylation exhibits "bimodal distribution" in the population, dividing individuals into **Fast Acetylators** and **Slow Acetylators**. 2. **Slow Acetylators:** These individuals have a deficiency of the NAT enzyme. They are at a higher risk of drug-induced toxicities, such as: * **Peripheral Neuropathy** with Isoniazid (due to Vitamin B6 deficiency). * **Drug-Induced Lupus Erythematosus (DILE)** with Hydralazine, Procainamide, and Isoniazid. 3. **Fast Acetylators:** They require higher doses of these drugs to achieve therapeutic levels and are more prone to **Hepatotoxicity** with Isoniazid (due to rapid conversion to the toxic metabolite acetylhydrazine).

Q: Which of the following substances can cross the blood-brain barrier?

Physostigmine. **Explanation:** The ability of a drug to cross the **Blood-Brain Barrier (BBB)** depends primarily on its lipid solubility and ionization state. To penetrate the CNS, a molecule must be **lipophilic** and **non-ionized**. **Why Physostigmine is Correct:** Physostigmine is a **tertiary amine** anticholinesterase. Unlike quaternary compounds, tertiary amines are uncharged (non-ionized) and highly lipid-soluble, allowing them to readily cross the BBB. This makes Physostigmine the drug of choice for treating central anticholinergic toxicity (e.g., Atropine poisoning). **Analysis of Incorrect Options:** * **Dopamine (A):** Although it is a neurotransmitter, dopamine is highly polar and does not cross the BBB. This is why **Levodopa** (a precursor that uses a transport carrier) is used in Parkinson’s disease instead of dopamine itself. * **Propranolol (B):** *Note: Propranolol actually DOES cross the BBB due to its high lipophilicity (causing side effects like vivid dreams).* However, in the context of this specific question format comparing it to the definitive "tertiary vs. quaternary" pharmacological principle of Physostigmine, Physostigmine is the classic textbook answer for "crossing the BBB" in cholinergic pharmacology. * **Glycopyrrolate (C):** This is a **quaternary ammonium** compound. It is permanently charged (ionized), making it lipid-insoluble and unable to cross the BBB. It is used when peripheral anticholinergic effects are desired without CNS side effects. **NEET-PG High-Yield Pearls:** 1. **Tertiary Amines (Cross BBB):** Physostigmine, Atropine, Scopolamine, Rivastigmine. 2. **Quaternary Amines (Do NOT cross BBB):** Neostigmine, Pyridostigmine, Edrophonium, Glycopyrrolate. 3. **Clinical Rule:** Use **Physostigmine** for Atropine poisoning (Central + Peripheral symptoms); use **Neostigmine** for Myasthenia Gravis (Peripheral action only).

Q: A patient reaches a steady state level of lithium that produces toxic side effects. If he decides to discontinue his medication, how long would it take for his lithium blood levels to reach 25% of his original steady state levels, assuming a half-life of 22 hours for lithium?

44 hours. ### Explanation **1. Understanding the Correct Answer (D: 44 hours)** The elimination of drugs following **first-order kinetics** (like Lithium) occurs at a constant fractional rate. The time required for the plasma concentration of a drug to reduce by 50% is defined as its **half-life ($t_{1/2}$)**. To reach 25% of the steady-state concentration, the drug must undergo **two half-lives**: * **After 1st half-life:** Concentration drops to 50% of the original level. * **After 2nd half-life:** Concentration drops to 25% (half of 50%). Given the $t_{1/2}$ of Lithium is 22 hours: $2 \times 22 \text{ hours} = \mathbf{44 \text{ hours}}$. **2. Analysis of Incorrect Options** * **Option A (11 hours):** This represents half of a half-life ($0.5 \times t_{1/2}$), which does not correspond to a standard elimination milestone. * **Option B (22 hours):** This is exactly one half-life. At this point, the concentration would be 50%, not 25%. * **Option C (33 hours):** This represents 1.5 half-lives. At this stage, the concentration would be approximately 35.3%. **3. Clinical Pearls for NEET-PG** * **Steady State Rule:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to completely eliminate a drug from the body (>95% washout). * **Lithium Kinetics:** Lithium is handled by the kidneys similarly to sodium. Dehydration, NSAIDs, and Thiazide diuretics can decrease its clearance, leading to toxicity. * **Therapeutic Index:** Lithium has a **narrow therapeutic index** (0.6–1.2 mEq/L). Toxicity typically manifests at levels >1.5 mEq/L with symptoms like coarse tremors, ataxia, and seizures. * **First-Order vs. Zero-Order:** Most drugs follow first-order kinetics (constant percentage per unit time). Only a few follow zero-order (constant amount per unit time), such as **P**henytoin, **A**lcohol, and **W**arfarin/High-dose **A**spirin (Mnemonic: **PAW**).

Q: A drug has 80% absorption and a hepatic extraction ratio of 0.4. Calculate the bioavailability of the drug?

48%. ### Explanation **1. Understanding the Correct Answer (C: 48%)** Bioavailability ($F$) is the fraction of an administered dose that reaches the systemic circulation in an unchanged form. When a drug is given orally, it must first be absorbed from the gut and then pass through the liver (first-pass metabolism). The formula for systemic bioavailability is: **$F = f \times (1 - ER)$** * **$f$ (Absorption):** 80% or 0.8 * **$ER$ (Extraction Ratio):** 0.4 * **$(1 - ER)$ (Hepatic Escape Fraction):** This represents the fraction of the drug that escapes hepatic metabolism. Here, $1 - 0.4 = 0.6$ (or 60%). **Calculation:** $F = 0.8 \times 0.6 = 0.48$ $0.48 \times 100 = \mathbf{48\%}$ **2. Why Other Options are Incorrect** * **A (12%):** This is a mathematical error, likely from multiplying half of the extraction ratio by a fraction of the absorption. * **B (32%):** This occurs if you incorrectly multiply the absorption (0.8) by the extraction ratio (0.4) instead of the escape fraction. This represents the amount metabolized, not the amount reaching circulation. * **D (64%):** This value is obtained if one ignores the extraction ratio and applies a different coefficient, or incorrectly calculates $0.8 \times 0.8$. **3. NEET-PG High-Yield Clinical Pearls** * **Definition:** Bioavailability of an **Intravenous (IV)** dose is always **100% (F=1)**. * **First-Pass Effect:** Drugs with a high Hepatic Extraction Ratio (e.g., **Lidocaine, Propranolol, Nitroglycerin**) have low oral bioavailability and are often given via non-enteral routes. * **Area Under the Curve (AUC):** Bioavailability is calculated by comparing the AUC of oral administration to the AUC of IV administration: $F = \frac{AUC_{oral}}{AUC_{IV}}$. * **Clinical Significance:** If a drug’s ER is >0.7, its bioavailability will be low, and small changes in hepatic enzyme activity can lead to significant changes in plasma drug levels.

Q: Which of the following statements about biotransformation is untrue?

More fat-soluble metabolites are formed.. ### Explanation **Biotransformation** (Drug Metabolism) is the chemical alteration of a drug in the body, primarily occurring in the liver. Its fundamental biological purpose is to convert **lipid-soluble (non-polar)** compounds into **water-soluble (polar)** compounds to facilitate excretion by the kidneys. #### Why Option C is Untrue (The Correct Answer) Metabolism aims to decrease lipid solubility. If metabolites were more fat-soluble, they would be reabsorbed by the renal tubules back into the systemic circulation, leading to drug accumulation and toxicity. Therefore, the formation of more fat-soluble metabolites is incorrect. #### Analysis of Other Options * **A & B: Inactive and Active metabolites are formed:** Most drugs are inactivated by metabolism (e.g., Paracetamol). However, some drugs are converted into **active metabolites** (e.g., Diazepam to Oxazepam) or are administered as **Prodrugs** (e.g., Enalapril to Enalaprilat), where metabolism is required for activation. * **D: More water-soluble metabolites are formed:** This is the primary goal of Phase I (Functionalization) and Phase II (Conjugation) reactions. Increasing polarity ensures the drug can be easily excreted in urine or bile. #### NEET-PG High-Yield Pearls * **Phase I Reactions:** Include Oxidation (most common), Reduction, and Hydrolysis. These primarily involve the **Cytochrome P450** enzyme system. * **Phase II Reactions:** Include Glucuronidation (most common), Acetylation, and Methylation. These usually result in total inactivation. * **Exception to the Rule:** Morphine-6-glucuronide is a rare example of a Phase II metabolite that is *more* active than the parent drug. * **First-Pass Metabolism:** Drugs with high first-pass metabolism (e.g., Nitroglycerin, Lidocaine) have low oral bioavailability.

Question 1

The study dealing with the effect of drugs on the body is known as:

Accepted Answer

Pharmacodynamics.

Answer

Pharmacokinetics.

Answer

Drug kinetics.

Answer

None.

Question 2

Which of the following is a Cytochrome P450 inhibitor?

Accepted Answer

Ketoconazole

Answer

Rifampicin

Answer

Phenytoin

Answer

None of the above

Question 3

Which drug is not acetylated?

Accepted Answer

Metoclopramide

Answer

Isoniazid

Answer

Dapsone

Answer

Hydralazine

Question 4

Chloroquine is given as a 600 mg loading dose because?

Accepted Answer

It has increased tissue binding.

Answer

It is rapidly absorbed.

Answer

It is rapidly metabolized.

Answer

It is rapidly eliminated.

Question 5

Which of the following substances can cross the blood-brain barrier?

Accepted Answer

Physostigmine

Answer

Dopamine

Answer

Propranolol

Answer

Glycopyrrolate

Question 6

A patient reaches a steady state level of lithium that produces toxic side effects. If he decides to discontinue his medication, how long would it take for his lithium blood levels to reach 25% of his original steady state levels, assuming a half-life of 22 hours for lithium?

Accepted Answer

44 hours

Answer

11 hours

Answer

22 hours

Answer

33 hours

Question 7

A drug has 80% absorption and a hepatic extraction ratio of 0.4. Calculate the bioavailability of the drug?

Accepted Answer

48%

Answer

12%

Answer

32%

Answer

64%

Question 8

Which pathological state alters the volume of distribution of many drugs?

Accepted Answer

Congestive heart failure

Answer

Septicemia

Answer

Duodenal ulcers

Answer

Hypertension

Question 9

In hepatic metabolism, which of the following are considered Phase II reactions?

Accepted Answer

All of these

Answer

Sulfation

Answer

Methylation

Answer

Glucuronidation

Question 10

Which of the following statements about biotransformation is untrue?

Accepted Answer

More fat-soluble metabolites are formed.

Answer

Inactive metabolites are formed.

Answer

Active metabolites are formed.

Answer

More water-soluble metabolites are formed.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?